Share price: 104.00p

Year End 2014 Prelim Statement

19th March 2015

Strong 2014 performance – robust gross profit growth.

Cello Group plc (AIM:CLL, “Cello” or “the Group”), the pharmaceutical and consumer strategic marketing group, today announces its final audited results for the year to 31 December 2014.

Year End 2014 Prelim Statement

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150